A method of treating a subject with high-risk multiple myeloma, a method of achieving a negative minimal residual disease status in a subject with multiple myeloma, and a possibility of relapse and/or disease progression in a subject with multiple myeloma Methods for predicting or reducing risk are disclosed.
展开▼
